Skip to main content
logo
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
3.370
+0.010 (0.30%)
At close: Mar 11, 2026, 4:00 PM EDT
3.360
-0.010 (-0.30%)
After-hours: Mar 11, 2026, 5:48 PM EDT

Acumen Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Cap
204103222222274-
Market Cap Growth
144.44%-53.52%0.38%-19.03%--
Enterprise Value
98.92-38.788.7543.9379.360
Last Close Price
3.371.723.845.406.76-
PE Ratio
--1.01-3.56-5.09-1.35-
PB Ratio
2.190.570.831.171.22-
P/TBV Ratio
2.190.570.701.160.60-
P/FCF Ratio
--1.20-5.16-6.27-15.20-
P/OCF Ratio
--1.20-5.16-6.30-15.23-
EV/EBITDA Ratio
-0.34-0.14-0.97-4.05-
EV/EBIT Ratio
-0.34-0.14-0.97-4.05-
EV/FCF Ratio
-0.45-0.20-1.24-4.41-
Debt / Equity Ratio
0.330.160.11000
Debt / EBITDA Ratio
-0.22-0.26-0.500.00--
Debt / FCF Ratio
-0.25-0.34-0.710.00--
Net Debt / Equity Ratio
-1.03-0.78-0.80-0.94-0.862.36
Net Debt / EBITDA Ratio
0.701.253.493.949.925.53
Net Debt / FCF Ratio
0.781.654.945.0310.795.88
Asset Turnover
-00000.06
Quick Ratio
5.776.2118.7722.7337.746.89
Current Ratio
6.026.4619.0123.0838.606.98
Return on Equity (ROE)
-96.99%-45.60%-22.98%-20.71%-76.44%-33.26%
Return on Assets (ROA)
-72.52%-41.53%-24.13%-21.19%-14.26%-30.58%
Return on Invested Capital (ROIC)
-745.54%-242.03%-186.22%-214.29%-127.82%5327.95%
Return on Capital Employed (ROCE)
-83.36%-44.84%-25.16%-21.86%-14.88%-35.93%
Earnings Yield
-65.33%-99.42%-28.13%-19.63%-74.26%-
FCF Yield
-60.62%-83.43%-19.37%-15.94%-6.58%-
Buyback Yield / Dilution
0.03%-7.64%-54.96%-1.76%-61.84%-
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q